Published Date: 31-May-2022
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report, published by KBV research, The Global Endovascular Aneurysm Repair Market size is expected to reach $3.6 billion by 2028, rising at a market growth of 4.8% CAGR during the forecast period.
The Abdominal segment is leading the Global Endovascular Aneurysm Repair Market by Indication in 2021, thereby, achieving a market value of $2.3 billion by 2028. Abdominal aortic aneurysm (AAA) is more frequent in the lower abdomen, with the majority of cases occurring in the infrarenal or juxtarenal regions of the lower abdomen. Furthermore, the market is expanding due to an increase in demand for minimally invasive treatments and the availability of advantageous reimbursements. Furthermore, according to statistics released by the Centers for Disease Control and Prevention (CDC) in 2019, AAA is most typically detected in people aged 65 and up. AAAs are expected to become more common as the world's population ages. As a result of these reasons, the market for abdominal aortic aneurysm repair devices is expected to increase
The Fenestrated Evar segment has shown growth rate of 5% during (2022 - 2028). Fenestrated EVAR (FEVAR) is a treatment option for people with abdominal aortic aneurysms who do not qualify for EVAR (about 10% of patients) because the aneurysm is too close to the arteries leading to the kidneys for regular EVAR to work.
The Infrarenal segment acquired maximum revenue share in the Global Endovascular Aneurysm Repair Market by Site in 2021; thereby, achieving a market value of $2.2 billion by 2028. The infrarenal segment acquired the largest revenue share in the endovascular aneurysm repair market in 2021. For infrarenal aneurysms, endovascular aneurysm repair (EVAR) has become the gold standard. Endografts in proximal diameters up to 36 mm are commercially available, providing proximal seal in necks up to 32 mm. At least 10 mm below the renal arteries, an infrarenal AAA appears. Since the renal arteries and superior mesenteric arteries are not involved, endovascular repair is most suited for infrarenal AAAs; however, with recent advancements, EVAR may also be employed for juxtarenal aneurysms.
The Complex segment is showcasing a CAGR of 6% during (2022 - 2028). Complex aortic aneurysms are defined by their size and involvement of side branches. Arch, thoracoabdominal, juxtarenal, and suprarenal aortic aneurysms are examples of complex aortic aneurysms. Beyond big tertiary care centers, open surgical repair has a significant rate of morbidity and mortality. Several technological advancements in the last decade have enabled the use of hybrid and total endovascular procedures to incorporate side branches. Patients with complex aneurysm anatomy have been treated with fenestrated and branched endografts.
The North America market dominated the Global Endovascular Aneurysm Repair Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1.3 billion by 2028. The Europe market is estimated to witness a CAGR of 4.6% during (2022 - 2028). Additionally, The Asia Pacific market would display a CAGR of 5.6% during (2022 - 2028).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Endologix LLC, Lombard Medical Limited, Cardinal Health, Inc., Becton, Dickinson and Company, Medtronic PLC, Cook Medical, Inc., Koninklijke Philips N.V., Terumo Corporation, Abbott Laboratories, and Artivion, Inc.
Unique Offerings from KBV Research